NCT01535443View on ClinicalTrials.gov

Safety and Tolerability of PRO-155 Ophthalmic Solution 0.09% in Healthy Volunteers.

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
InflammationCataract
Interventions
DRUG

Bromfenac

Drug: Bromfenac Other names: PRO-155

Trial Locations (1)

44690

"Unidad Medica Grupo Pediátrico", Guadalajara

All Listed Sponsors
lead

Laboratorios Sophia S.A de C.V.

INDUSTRY

NCT01535443 - Safety and Tolerability of PRO-155 Ophthalmic Solution 0.09% in Healthy Volunteers. | Biotech Hunter | Biotech Hunter